Form EFFECT Mereo BioPharma Group
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 4, 2024 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mereo BioPharma (MREO) Reports In-Line Q2 EPS
- Crypto News Today: Bitcoin ETFs Lose $192M in 2 Days as AlphaPepe Buyers Hunt the Next PEPE Before the Chart
- Mereo BioPharma licenses alvelestat to Sentynl for U.S. market
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
